Skip to content
October 20, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Breast Cancer Legislation and Policy
  • The Great Dismantling: An Analysis of the Radical Restructuring of U.S. Global Health Policy
  • Breast Cancer Legislation and Policy

The Great Dismantling: An Analysis of the Radical Restructuring of U.S. Global Health Policy

Evan Lee Salim August 24, 2026 7 minutes read
the-great-dismantling-an-analysis-of-the-radical-restructuring-of-u-s-global-health-policy

Editorial Note: Originally published in May 2025, this report has been extensively updated to reflect the evolving landscape of U.S. foreign assistance following the aggressive executive restructuring initiated by the Trump administration’s second term.


Introduction: A Paradigm Shift in Foreign Aid

In a move that has sent shockwaves through the international development community, the first days of President Trump’s second term marked the beginning of a systematic dismantling of the traditional U.S. global health architecture. By prioritizing a "restructuring" mandate, the administration has effectively signaled the end of the post-World War II era of expansive U.S. foreign assistance. Through a series of executive orders, a comprehensive "stop-work" freeze, and the dissolution of the United States Agency for International Development (USAID), the White House has fundamentally altered how the United States engages with the global community on health, humanitarian, and developmental issues.

This report examines the mechanics of these changes, the current operational status of surviving programs, and the profound implications for global health security, American soft power, and the millions of vulnerable populations who previously relied on U.S.-funded health initiatives.


Chronology of Administrative Action

The transition from a robust global health footprint to the current period of uncertainty occurred with unprecedented speed. The sequence of events reflects a coordinated effort to dismantle the institutional apparatus of American aid.

  • Day 1 (Inauguration): The President signs Executive Order 14101, mandating a comprehensive 90-day review of all foreign assistance programs, citing a need to ensure "maximum efficiency and alignment with American interests."
  • Day 3: A formal "stop-work" directive is issued to all federal agencies involved in international aid. This directive immediately froze payments and services for active contracts, grants, and cooperative agreements, effectively paralyzing ongoing medical interventions in conflict zones and developing nations.
  • Day 14: The administration announces the dissolution of USAID. Personnel reduction notices are issued, and the agency begins the process of liquidating assets and cancelling existing award agreements.
  • Day 30: A narrow, highly restricted waiver process is established for "life-saving humanitarian assistance." However, internal reports from implementing partners suggest the bureaucracy surrounding these waivers is designed to discourage applications rather than facilitate them.
  • Day 60: The formal transfer of remaining global health oversight to the State Department is completed, leaving the infrastructure of public health policy in the hands of diplomats rather than technical health experts.

The Dismantling of USAID: An Institutional Collapse

The dissolution of USAID represents perhaps the most significant change in U.S. foreign policy in decades. USAID had served as the primary engine for U.S. health efforts, including the President’s Emergency Plan for AIDS Relief (PEPFAR) and the President’s Malaria Initiative (PMI).

By dissolving the agency, the administration has stripped away the specialized technical expertise—epidemiologists, logistics experts, and field researchers—that allowed the U.S. to operate in challenging environments. While some remnants of these programs have been folded into the State Department’s Bureau of Global Health Security, critics argue that the institutional knowledge has been irrevocably lost. The reduction in force (RIF) has led to a brain drain, as veteran civil servants have resigned or retired in protest or out of necessity.


Supporting Data: The Cost of Disruption

The impact of these changes is quantifiable, though the full scope of the fallout remains obscured by the lack of transparency in current reporting.

1. The Financial Freeze

Data indicates that billions of dollars in obligated funds remain "trapped" in a state of suspended animation. Approximately $14.2 billion in multi-year grant commitments were abruptly terminated within the first quarter of 2025. This has led to a cascade of bankruptcies among smaller, non-governmental organizations (NGOs) that served as the primary contractors for U.S. aid.

2. Service Gaps

Internal State Department briefing documents—leaked to various outlets—estimate that vaccine supply chains in Sub-Saharan Africa and Southeast Asia have been disrupted by as much as 40%. The cessation of U.S. funding for malaria bed-net distribution has left an estimated 12 million households without protection, leading to projected increases in malaria-related mortality for the 2025–2026 season.

3. Legal Challenges

To date, over 40 lawsuits have been filed against the administration by a coalition of public health advocates and former aid contractors. The legal arguments center on the Administrative Procedure Act, asserting that the sudden cancellation of awards without due process or congressional oversight exceeds executive authority. However, the judiciary has been hesitant to issue injunctions, often citing the President’s broad authority over foreign policy.


Official Responses and Justifications

The administration maintains that these actions are necessary to curb "wasteful spending" and ensure that American resources are not being diverted to corrupt entities or programs that do not directly benefit the U.S. taxpayer.

A spokesperson for the White House stated in a recent press briefing:

"For too long, American foreign aid has been a slush fund for entrenched bureaucratic interests. We are resetting the clock to ensure that every dollar spent serves the American people and our national security interests first. The reorganization into the State Department allows for a more streamlined, top-down approach that prioritizes our strategic alliances over globalist welfare."

Conversely, former USAID administrators and health officials have described the move as a "strategic catastrophe." They argue that global health programs are not merely charity; they are a critical component of national security. By preventing pandemics at their source, the U.S. protects its own borders—a logic the current administration has largely dismissed in favor of an isolationist stance.


Implications for the Future of Global Health

The Loss of U.S. Leadership

The United States has historically been the world’s largest donor to global health. The withdrawal of this support leaves a vacuum that other global powers, specifically China and Russia, are already moving to fill. This shift is not merely financial; it is geopolitical. As the U.S. retreats, nations in the Global South are reorienting their diplomatic and medical partnerships, potentially weakening the long-term influence of the U.S. in regions where health security is a primary driver of stability.

The HHS Reorganization

Beyond the State Department, the Department of Health and Human Services (HHS) is undergoing its own transformation. Proposed budget cuts suggest that the Centers for Disease Control and Prevention (CDC) will see a significant reduction in its global mission. The "domestic-first" policy mandates that CDC experts be recalled from international posts, limiting the U.S. capacity to detect emerging pathogens before they become global threats.

Human Rights and Vulnerable Populations

The most immediate and tragic impact will be felt by marginalized communities. Programs targeting HIV/AIDS, tuberculosis, and maternal health have been hit hardest. The difficulty of obtaining the "life-saving" waivers mentioned in the executive orders means that clinics in rural areas—those most reliant on U.S. support—are the first to close. We are witnessing a reversal of decades of progress in life expectancy and maternal mortality in several developing nations.


Conclusion: What to Watch in the Coming Months

As the second year of this administration progresses, observers should watch for the following markers of the "new normal":

  1. The Rise of Bilateralism: Will the administration move toward a system of direct, bilateral agreements that bypass traditional development goals in favor of transactional diplomatic exchanges?
  2. Private Sector Displacement: There are indications that the administration intends to replace NGO-led programs with private-sector contracts, prioritizing for-profit entities over humanitarian mission-driven organizations.
  3. Congressional Pushback: While the administration has exercised broad executive power, the next budget cycle will be the true test. Will Congress attempt to claw back funding for global health, or will they defer to the White House’s vision of a restructured foreign policy?
  4. Health Security Data: Watch for emerging epidemiological reports from the World Health Organization (WHO) that may reflect the impact of the U.S. withdrawal on global disease surveillance.

The landscape of U.S. foreign assistance has been permanently altered. The era of the "global health superpower" appears to have concluded, replaced by a more insular, state-centric approach that views health aid not as a moral or security imperative, but as a secondary policy tool to be wielded or discarded at will. The consequences of this shift will likely reverberate for a generation.

About the Author

Evan Lee Salim

Author

View All Posts

Post navigation

Previous: Advancing the Frontlines: A President’s Dispatch on the Future of Metastatic Breast Cancer Research
Next: Finding Pride in the Aftermath: How One Individual’s Journey Through Grief Redefined Community

Related Stories

the-patchwork-safety-net-mapping-the-disparities-in-american-medicaid-coverage
  • Breast Cancer Legislation and Policy

The Patchwork Safety Net: Mapping the Disparities in American Medicaid Coverage

Siti Muinah October 20, 2026
mapping-the-safety-net-understanding-the-divergent-landscapes-of-medicaid-and-chip-in-2026
  • Breast Cancer Legislation and Policy

Mapping the Safety Net: Understanding the Divergent Landscapes of Medicaid and CHIP in 2026

Lina Hope October 19, 2026
the-great-divide-assessing-the-evolution-and-impact-of-the-aca-medicaid-expansion-2
  • Breast Cancer Legislation and Policy

The Great Divide: Assessing the Evolution and Impact of the ACA Medicaid Expansion

Nana Wu October 19, 2026

Recent Posts

  • Unveiling a Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Breast Tumors Hijack Immune Cells to Grow Nerves
  • Where options run out, BRIA-ABC bets on survival in metastatic breast cancer
  • Navigating the Nexus: GLP-1 Medications and Breast Cancer Risk, Recurrence, and Treatment
  • Global Illumination: 325 Landmarks to Shine Light on Metastatic Breast Cancer Research This October
  • A New Era in Oncology: Karen and Rob Hale Commit Historic $50 Million to Breast Cancer Research Foundation

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

unveiling-a-cancers-devious-strategy-ou-researchers-discover-how-aggressive-breast-tumors-hijack-immune-cells-to-grow-nerves
  • Medical Research and Clinical Trials

Unveiling a Cancer’s Devious Strategy: OU Researchers Discover How Aggressive Breast Tumors Hijack Immune Cells to Grow Nerves

Reynand Wu October 20, 2026
where-options-run-out-bria-abc-bets-on-survival-in-metastatic-breast-cancer-1
  • Medical Research and Clinical Trials

Where options run out, BRIA-ABC bets on survival in metastatic breast cancer

Ali Ikhwan October 20, 2026
navigating-the-nexus-glp-1-medications-and-breast-cancer-risk-recurrence-and-treatment
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer Risk, Recurrence, and Treatment

Ammar Sabilarrohman October 20, 2026
global-illumination-325-landmarks-to-shine-light-on-metastatic-breast-cancer-research-this-october
  • Patient Advocacy and Support

Global Illumination: 325 Landmarks to Shine Light on Metastatic Breast Cancer Research This October

Rifan Muazin October 20, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.